ライフサイエンスコーパス: healthy control

1 ity of 90% (16 bladder cancer patients and 8 healthy controls).

2 ment, compared to 115 age and gender-matched healthy controls).

3 sciatica patients and 5 healthy volunteers (healthy controls).

4 n-alpha, patients with major depression, and healthy controls).

5 elihood to develop MCI, dementia or die than healthy controls).

6 Data were compared with healthy controls.

7 inflamed ankles compared with the ankles of healthy controls.

8 present in 30% of RTRs compared with 11% of healthy controls.

9 IFNG, CCL3, CLL4, GZMB, and IL10 compared to healthy controls.

10 PVT2 patient (D307H-CASQ2 mutation) and from healthy controls.

11 es during pVEP, compared to those without or healthy controls.

12 nishment groups adapted to similar degree as healthy controls.

13 bral blood flow (rCBF) in adults with SZ and healthy controls.

14 nal capacities nearly equivalent to those of healthy controls.

15 ty Medical Center (Leiden, Netherlands), and healthy controls.

16 mean duration of illness of 18 years) and 46 healthy controls.

17 women with ovarian cancer but in none of 50 healthy controls.

18 gher in RA, compared with osteoarthritis and healthy controls.

19 T cells was increased compared with that in healthy controls.

20 teen patients with sepsis and 19 age-matched healthy controls.

21 gher Cho (p < 0.001) at TEA when compared to healthy controls.

22 cted histamine intolerance, food allergy and healthy controls.

23 ve memories equally well in SAD patients and healthy controls.

24 pic patient samples as well endometrium from healthy controls.

25 MS patients not undergoing treatment and 71 healthy controls.

26 re reduced in patients with MS compared with healthy controls.

27 ed more in the partner context compared with healthy controls.

28 ons of fibroblasts derived from patients and healthy controls.

29 set of dengue shock syndrome (DSS), and from healthy controls.

30 iacylglycerol (1)H NMR signals over those of healthy controls.

31 with sporadic Parkinson's disease, and nine healthy controls.

32 ss relative to their own speech comparedwith healthy controls.

33 atients with first-episode psychosis and 105 healthy controls.

34 set intervals out to 28 days, and also in 18 healthy controls.

35 Two hundred twenty BSCR patients and 59 healthy controls.

36 led as compared to controlled asthmatics and healthy controls.

37 in discriminating infections as compared to healthy controls.

38 ated in children with active CMA compared to healthy controls.

39 sporadic Parkinson's disease and age-matched healthy controls.

40 dependent group of 26 asthma patients and 12 healthy controls.

41 hora who were listed for punctoplasty and 20 healthy controls.

42 evaluate miRNome in children with CMA and in healthy controls.

43 Microbiome type IV was not detected in healthy controls.

44 sma and tissue samples from CRC patients and healthy controls.

45 lted upregulated in CMA patients compared to healthy controls.

46 patients with stable graft function, and 58 healthy controls.

47 mulation with Escherichia coli compared with healthy controls.

48 ces more negative in SAD patients but not in healthy controls.

49 with AIS, without previous treatment, and 10 healthy controls.

50 d locusts performed more MMM behaviours than healthy controls.

51 and end point in 41 patients and once in 39 healthy controls.

52 hundred fifty-five glaucoma patients and 35 healthy controls.

53 o-RGC density ratios was relatively large in healthy controls.

54 leftward asymmetry that was not observed in healthy controls.

55 imaged, and compared to the results from 10 healthy controls.

56 with hepatitis B virus monoinfection and 18 healthy controls.

57 erotic cardiovascular disease (ACVD) and 187 healthy controls.

58 n and lung fibroblasts from SSc patients and healthy controls.

59 nts during a major depressive episode and 35 healthy controls.

60 e AMD, 46 patients with atrophic AMD and 111 healthy controls.

61 significant cognitive decline compared with healthy controls.

62 cone-to-RGC ratios in glaucoma patients and healthy controls.

63 rn in the cerebellum between PD patients and healthy controls.

64 ticipants with major depressive disorder and healthy controls.

65 detected in sera of pSS patients compared to healthy controls.

66 rtate receptor (NMDAR)-more commonly than do healthy controls.

67 gets expression, similar to that observed in healthy controls.

68 -5p (P = 0.016) in AD patients compared with healthy controls.

69 ved peak O2 consumption within the ranges of healthy controls.

70 e left putamen compared with TD patients and healthy controls.

71 s that are intermediate between probands and healthy controls.

72 ients with either mild sepsis or age-matched healthy controls (15.7 vs 49.5 vs 66.5 nmol/L; p = 0.000

73 plasma NFL concentration in 193 cognitively healthy controls, 197 patients with mild cognitive impai

74 Among 193 cognitively healthy controls, 197 patients with mild cognitive impai

75 between prospectively collected samples from healthy controls (2.66 units/mg protein) and samples fro

76 nd categorized equally into three groups: 1) healthy (control); 2) chronic periodontitis (CP); and 3)

77 Thirty-seven healthy controls (25 females, mean age 34.4 years) were

78 (IQR) follow-up of 5.3 y (4.8-6.1 y) and 357 healthy controls (47% male; age 54 +/- 11 y), baseline v

79 A total of 69 healthy controls, 86 SMD, 45 MCI, and 38 AD patients wer

80 ateral prefrontal functional connectivity in healthy controls, a region implicated in decision-making

81 poradic Parkinson's disease, and age-matched healthy controls, all aged 18 years or older.

82 omerase I antibody-positive patients and 561 healthy controls, all of Japanese descent.

83 pectancies in alcohol-dependent patients and healthy controls and assessed treatment outcome in patie

84 We did a retrospective analysis of healthy controls and carriers of CAG expansion mutations

85 terms of extent, strength, and topography to healthy controls and different from non-TMSR patients.

86 erythematosus were demethylated compared to healthy controls and favoured production of IL-6 when cu

87 lu was lower in adults with SZ compared with healthy controls and in older adults versus younger adul

88 ing PLP concentrations of RTRs with those of healthy controls and investigated long-term clinical imp

89 measured in airway epithelial brushings from healthy controls and patients with asthma.

90 -5p, miR-125b-5p and miR-27b-3p, compared to healthy controls and receiver operator curves of the miR

91 e fear network connectivity differed between healthy controls and the anxiety group during fear learn

92 h AD, ADHD, comorbid AD/ADHD and age-matched healthy controls and to investigate aspects of AD relate

93 presence of counterfactual feedback in both healthy controls and unmedicated GTS patients, this was

94 Peripheral blood mononuclear cells from healthy controls and viremic KTR were stimulated using B

95 worse functional vitamin B-6 status than do healthy controls and vitamin B-6-sufficient RTRs.

96 thy (AMN), heterozygote female carriers, and healthy controls and, in addition, correlate antioxidant

97 (mean duration of illness of 7 years) and 79 healthy controls, and Data set 2: an independent cohort

98 ization of repeat-bound proteins to resemble healthy controls, and efficient reversal of DM1-associat

99 otype distribution was comparable in KTR and healthy controls, and greater proportions of NKG2C(+) ce

100 cantly from either schizophrenia patients or healthy controls, and it was intermediate between the tw

101 ntractile platelet subpopulations present in healthy controls are conspicuously absent in a subset of

102 Compared with 20 healthy controls, ARVC patients had longer ventricular a

103 ofiles of fibroblasts from LOAD patients and healthy controls, as a function of age and disease.

104 ients with HS (lesional and nonlesional) and healthy controls between October 1, 2014, and August 1,

105 with the laryngeal form of dystonia (LD) and healthy controls (both males and females), we identified

106 lood or liver of cHBV patients compared with healthy controls, but they had higher percentages of CD3

107 dings of WES using 151 leprosy cases and 226 healthy controls by Sanger sequencing.

108 atients with first-episode schizophrenia and healthy controls by using magnetic resonance imaging wer

109 PVT2-hiPSC cardiomyocytes when compared with healthy control cells.

110 ssing a problem in their relationship with a healthy control companion.

111 -intact patients and 21 age- and sex-matched healthy controls completed a right-hand, paced tapping f

112 ently abstinent methamphetamine users and 15 healthy controls completed two laboratory paradigms of '

113 ed amyloid pathology compared to age-matched healthy controls, confirming our experimental results.

114 These findings in healthy controls converge with the effective contacts in

115 ic steatohepatitis (NASH), or obesity and 54 healthy controls (CTRLs), matched in a case-control fash

116 Additionally, monocytes from healthy controls, cultured in the presence of both sera

117 Patients with asthma and healthy controls differ in bacterial colonization of the

118 Whereas purified fibrinogen from healthy controls displayed no post-translational modific

119 tional less cautious style closer to that of healthy controls emphasizing its adaptive nature.

120 poactivation of the motor cortex relative to healthy controls, even when controlling for performance.

121 The results showed that healthy controls exemplified better cognition than patie

122 hy and severe asthmatic subjects compared to healthy controls' exosomes.

123 omenon was also observed in neutrophils from healthy controls exposed to patient plasma samples or ex

124 AZOOR line was 60 (26) times higher than in healthy control eyes (P = .03) at equivalent fundus loca

125 bited proliferation and migration of SSc and healthy control fibroblasts and attenuated basal and tra

126 A healthy control group (HC, n = 168) was composed accordi

127 CV group, and the corresponding rates in the healthy control group were 1.26%, 10.13%, 39.24%, and 49

128 o rely on the same dynamic network as in the healthy control group, the medial prefrontal cortex had

129 articipants showing addictive behaviors; and healthy control group.

130 across a continuum of sarcoidosis severity (healthy control --> uncomplicated sarcoidosis --> compli

131 PBMs from healthy controls had lower SIRT1 and SIRT7 and readily f

132 At baseline, HDC and healthy controls had no significant differences in their

133 Thirty-one healthy controls (Hamilton Depression Rating Scale-24 it

134 PET radioligand (18)F-AV-1451 in cognitively healthy control (HC) and Alzheimer disease (AD) subjects

135 ed a cross-sectional sample of 34 MDD and 26 healthy control (HC) subjects, with high-resolution magn

136 with peanut-specific TR1 cells induced from healthy control (HC) subjects.

137 blood NGF data in SCZ patients compared with healthy control (HC) subjects.

138 Eleven CD and 12 healthy controls (HC) completed two positron emission to

139 is study, seventeen patients and age-matched healthy controls (HC) performed a variant of the Stroop

140 ghty-two patients with progressive MS and 46 healthy controls (HC) were enrolled in this cross-sectio

141 ith nonpsychotic major depression (NPMD) and healthy controls (HC) were studied.

142 sive (AgP) or chronic periodontitis (CP) and healthy controls (HC), as well as elucidate its associat

143 m subjects with AD, PS, and CD compared with healthy controls (HC).

144 novo Parkinson's disease (PD) compared with healthy controls (HC).

145 RR) MS patients, progressive MS patients and healthy controls (HC).

146 sNfL levels were measured in healthy controls (HC, n = 254) and two independent MS co

147 ), ADHD-only (ie, without AD), AD + ADHD and healthy controls (HC; ie, no AD/no ADHD).

148 who are unmedicated at baseline (n=423) and healthy controls (HC; n=196).

149 17 patients with MS and 11 healthy controls (HCs) underwent 3 experimental sessions

150 -free rrMDD patients (2 MDD episodes) and 41 healthy controls (HCs) were recruited.

151 nitive impairment (aMCI), and 10 cognitively healthy controls (HCs).

152 ersons with traumatic brain injury (TBI) and healthy controls (HCs).

153 ithout ICB over follow-up (PD-no-ICB) and 42 healthy controls (HCs).

154 109 BD patients and 36 age- and sex-matched healthy controls (HCs).

155 st-traumatic stress disorder (PTSD), and 122 healthy controls (HCs).

156 ctional area was measured in individuals (24 healthy controls [HCs], 17 asymptomatic carriers of HTLV

157 ood plasma were prospectively collected from healthy controls, heterozygote female carriers, and pati

158 arpine-temporal lobe epilepsy model) and 100 healthy control hippocampi, we identified 256 RNA sites

159 erum levels of pro-inflammatory cytokines as healthy controls; however, donor blood had increased neu

160 h atherosclerotic cardiovascular disease and healthy controls, identifying microbial strains and func

161 ome in HS differs significantly from that in healthy controls in lesional and nonlesional skin.

162 ystic ovary syndrome (PCOS) and systemically healthy controls in the presence or absence of gingiviti

163 ] age, 63.7 [9.9] years) and 20 eyes from 20 healthy control individuals (9 men and 11 women; mean [S

164 nts with suspected MA, and non-meat-allergic healthy control individuals (HC), were analyzed via sing

165 mmatory markers in participants with ALS and healthy control individuals and to track immune changes

166 when compared against those for samples from healthy control individuals.

167 ivation in the dorsal striatum compared with healthy control individuals.

168 Here we show that, relative to healthy controls, inflamed intestinal tissues from patie

169 , 46.9 [14.0] years; 19 [63% female]) and 24 healthy controls (mean [SD] age, 32.2 [12.0] years; 13 [

170 pressing both kappa and lambda compared with healthy controls (median [interquartile range] 4.1% [2.4

171 o induced in CVB3-induced myocarditis versus healthy control mice.

172 expressed (DE) genes between sarcoidosis and healthy control monocytes.

173 We classified data on eyes into healthy controls, multiple-sclerosis-associated optic ne

174 ere used to classify each TMJ data sample as healthy control ( n = 124) or TMJOA ( n = 130).

175 ients (n = 14; 28 eyes) and age-/sex-matched healthy controls (n = 14; 28 eyes) were enrolled.

176 (n = 59) compared to psoriasis (n = 22) and healthy controls (n = 18).

177 N = 28) with MDD and age- and gender-matched healthy controls (N = 18).

178 genates of patients with CRSwNP (n = 21) and healthy controls (n = 21) and on primary epithelial cell

179 , simple steatosis but no NASH (n = 11), and healthy controls (n = 23), we discovered a liver-specifi

180 x recipients (n = 22 stable, n = 13 BOS) and healthy controls (n = 25) were cultured as primary cell

181 differentiate during reversal compared with healthy controls (n = 35), although significant differen

182 nonsevere (n = 109) falciparum malaria, and healthy controls (n = 50), we measured parasite biomass,

183 bladder cancer patients (n = 16) compared to healthy controls (n = 8).

184 om IgE-mediated allergic rhinitis (n=10) and healthy controls (n=10).

185 Healthy controls (n=12), patients treated with clozapine

186 rtFTD (n=14), nfvPPA (n=16), eoAD (n=17) and healthy controls (n=156) were recorded (video and audio)

187 ulitis observed longitudinally (n=82) and of healthy controls (n=32).

188 ed with UHR subjects who remitted (n=41) and healthy controls (n=54).

189 Gender-matched healthy controls (n=68) also underwent MRI scanning.

190 etime history of Axis I psychopathology (ie, healthy controls; n=26).

191 ould be induced experimentally by incubating healthy control neutrophils with soluble sputum from pat

192 cement mutation frequencies than observed in healthy controls or patients with other neurological dis

193 parameter were estimated from variability in healthy controls over 1 year.

194 sed in exudative AMD patients, compared with healthy controls (P < 0.001) and atrophic AMD patients (

195 SAH versus alcoholic cirrhosis patients and healthy controls (P < 0.05).

196 -DR7 was present in 88% compared to 19.6% in healthy controls (p = 4.1 x 10(-11) ).

197 ients with SCN compared with 3.9 +/- 0.4 for healthy controls (P = NS).

198 and caudate of RC BD-I patients compared to healthy controls (P<0.005) and in ACC compared to non-RC

199 that in peripheral blood from BC patients or healthy controls (P<0.05).

200 with the results of the age- and sex-matched healthy control participants (n = 20).

201 A total of 201 healthy control participants and 375 patients with psych

202 ging protocol was demonstrated by using five healthy control participants and five patients with type

203 ts experiencing a first episode of BD and 28 healthy control participants at 4T and quantified creati

204 n patients with axis I disorders and matched healthy control participants during cognitive control ta

205 tions across the two disorders with those in healthy control participants using both categorical and

206 ive first-episode psychosis patients, and 19 healthy controls, participated in a quantitative neuroim

207 24 heart transplant candidates (HTx)-and 97 healthy controls performed a maximal graded cardiopulmon

208 follow-up of 5.3 y (IQR: 4.8-6.1 y) and 297 healthy controls, PLP, plasma 3-hydroxykynurenine (3-HK)

209 sthmatic children (n = 30) by using a shared healthy control population (n = 36) and in an independen

210 S approach on four leprosy patients and four healthy control relatives from two leprosy families.

211 30 MC-negative HCV-infected patients and 15 healthy controls revealed that frequencies of class-swit

212 poradic Parkinson's disease, and age-matched healthy controls seen from November, 2012, to May, 2016,

213 rare but more common in pNF subjects than in healthy control subjects (4 versus 1).

214 ources more narrowly but more intensely than healthy control subjects (HCS).

215 ubjects with schizophrenia (SCH) relative to healthy control subjects (HCs).

216 lated in patients with IS compared with both healthy control subjects (miR-125a-5p [1.8-fold; P=1.5x1

217 n, and compared their performance to matched healthy control subjects (n = 18), in behavioural tasks

218 th generalized anxiety disorder (n = 24) and healthy control subjects (n = 20), patients with post-tr

219 th pathological anxiety (n = 25) and matched healthy control subjects (n = 23) completed a gambling t

220 ith idiopathic or heritable PAH (n=365) from healthy control subjects (n=121) after correction for mu

221 ofile (n=38), MCI with AD profile (n=20) and healthy control subjects (n=20).

222 We recruited 80 healthy control subjects and AD patients with and withou

223 atment-seeking cocaine users (NTSCUs) and 67 healthy control subjects and an independent treatment-co

224 MCs were isolated from patients with PAH and healthy control subjects and assessed for expression of

225 ents with neurodegenerative disease and 4351 healthy control subjects and found p.A152T associated wi

226 No significant difference was found between healthy control subjects and glaucoma patients in the me

227 icantly reduced in MS patients compared with healthy control subjects and other inflammatory neurolog

228 e differentiation and monocyte activation in healthy control subjects and patients with autoinflammat

229 5b-5p, and miR-143-3p differentiated between healthy control subjects and patients with IS with an ar

230 data and biospecimens from 909 AA and 847 EA healthy control subjects from the Carolina Breast Cancer

231 ubjects had 11C-Pittsburgh compound B and 10 healthy control subjects had 11C-(R)-PK11195 positron em

232 Twelve age-matched healthy control subjects had 11C-Pittsburgh compound B a

233 e patients with Alzheimer's disease and five healthy control subjects to analyse the presence of phos

234 patients with relapsing-remitting MS and 20 healthy control subjects underwent a 3-T resting-state f

235 Patients with stable asthma and healthy control subjects underwent spirometry, methachol

236 ood from patients with atopic dermatitis and healthy control subjects was analyzed with flow cytometr

237 ith PD (54 with MCI, 116 without MCI) and 41 healthy control subjects was obtained by using determini

238 2D (HbA1c >7.5%) and 24 age- and sex-matched healthy control subjects were consecutively enrolled.

239 Twenty-eight patients with CSM and 10 healthy control subjects were prospectively recruited an

240 gram [GSK-HiTDiP] study (113 patients and 57 healthy control subjects) and the Janssen-Brain Resource

241 ols), replication (200 patients with IS, 100 healthy control subjects), and in 72 patients with trans

242 ents with Gram-negative sepsis compared with healthy control subjects.

243 els for total cell-free circulating RNA from healthy control subjects.

244 patients with ET and 18 age- and sex-matched healthy control subjects.

245 man serum samples from lymphoma patients and healthy control subjects.

246 hronic schizophrenia patients and 26 matched healthy control subjects.

247 acteria and less Bacteroidetes compared with healthy control subjects.

248 of patients with CVID compared with those of healthy control subjects.

249 te allergens in DOCK8-deficient patients and healthy control subjects.

250 as a higher prevalence of LGE compared with healthy control subjects.

251 striatum in 13 pathological gamblers and 15 healthy control subjects.

252 from patients with mild-to-severe asthma and healthy control subjects.

253 urological memory-disordered patients and 14 healthy control subjects.

254 splay methylation levels similar to those of healthy control subjects.

255 unced evidence of inflammation compared with healthy control subjects.

256 26 with bipolar disorder) and 50 age-matched healthy control subjects.

257 re strongly connected to one another than in healthy control subjects.

258 d, moderate, and severe asthma and nonatopic healthy control subjects.

259 e loop in chronic schizophrenia patients and healthy control subjects.

260 ated, mild-to-moderate disease compared with healthy control subjects.

261 o-striatal-thalamo-cortical motor circuit in healthy controls, TD patients, and PIGD patients before

262 density ( P = 0.009) compared to age-matched healthy control teeth.

263 fungicidal activity compared with those from healthy controls that improved in the presence of recomb

264 ss the whole brain in patients compared with healthy controls that overlap with significant increases

265 ameter at 100 mum depth on OCT compared with healthy controls; this was not observed in patients whos

266 s from patients with Parkinson's disease and healthy controls to construct an ensemble of models to p

267 epithelial cells (HBECs) from asthmatics and healthy controls to evaluate: (i) ADMA-mediated NOS unco

268 rend in the severity score was observed from healthy control, to uncomplicated sarcoidosis, and final

269 ot reduce IL-10 secretion as was observed in healthy control transitional B cells.

270 Eleven healthy controls underwent 2 sessions of MRI for reprodu

271 ng 2012-2013, 175 subjects with MetS and 226 healthy controls underwent ECG recordings of at least 4

272 d two with 'right' semantic dementia) and 12 healthy controls underwent positron emission tomography

273 Ninety-nine frequency-matched healthy controls underwent testing at commensurate time

274 plex CHD prior to surgery and 30 age-matched healthy controls using brain MRI.

275 ive, first-episode psychosis patients and 16 healthy controls using PET and the TSPO radioligand [(11

276 ar cells (PBMNCs) isolated from patients and healthy controls using RT-qPCR and receiver operating ch

277 We compared IPD patients with 33 healthy controls using z score analysis; RI values </= 2

278 separate study, we replicate in humans (154 healthy controls) using resting state functional connect

279 itudes from 34 schizophrenia patients and 33 healthy control volunteers were compared.

280 a significantly higher relative abundance in healthy controls vs HS skin, indicating that Propionibac

281 For 22 HCV(+) patients and 7 healthy controls, we performed high-throughput sequencin

282 me responses and the profiles of welders and healthy controls were alike.

283 230 healthy controls were also included.

284 (MRI) scans from 2148 MDD patients and 7957 healthy controls were analysed with harmonized protocols

285 putamen of 16 RC BD-I, 34 non-RC BD-I and 44 healthy controls were assessed.

286 serum proteins and DTI measures reported in healthy controls were disrupted in MA and MAP groups; th

287 cts per group with RA, PsA, OA or IBD and 50 healthy controls were included in the study.

288 serologic tests or detection of ova) and 17 healthy controls were included in the study.

289 nts with a first episode of psychosis and 74 healthy controls were included.

290 sing 353 untreated patients with OSA and 444 healthy controls were included.

291 ewly diagnosed patients with MetS along with healthy controls were recruited for this cross-sectional

292 sepsis from two large U.K. hospitals and 20 healthy controls were recruited.

293 In addition, 30 healthy controls were studied.

294 crobiota from patients with constipation and healthy controls were transplanted into the antibiotic d

295 stool of 183 subjects (82 UC, 50 CD, and 51 healthy controls) were determined.

296 MII-pH measurements on-PPI and with healthy controls will be useful in the further elucidati

297 We found that patients with OCD outperformed healthy controls, winning significantly more points.

298 in patients with multiple sclerosis (MS) and healthy controls with a 5-year follow-up and to analyze

299 men suffering rUTIs, compared to age-matched healthy controls with concentrations further decreased (

300 er measures of GMV in these regions than the healthy controls with the same allele, whereas those wit

301 In contrast, compared with CD/CU- and healthy control youths, CD/CU+ youths showed diminished